FDA
- Status: approved
🇺🇸 A second dose with an 3 year interval in United States
A second dose with an 3 year interval (A second dose with an 3 year interval) regulatory status in United States.
Marketing authorisation
A second dose with an 3 year interval in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is A second dose with an 3 year interval approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for A second dose with an 3 year interval in United States?
Shanghai Municipal Center for Disease Control and Prevention is the originator. The local marketing authorisation holder may differ — check the official source linked above.